Is of great interest to identify in future the spectrum of tumor-specific sets of RAGE ligands, and to examine how cooperation of M1 or M2-specific receptors with RAGE can a decide about pro-and anti-tumor programming of TAMs. Here, AGER is linked to neoplasm.